Clinical results of radical prostatectomy for patients with prostate cancer in Macau

Chinese Medical Journal

Volumn 121, Issue 4, 2008, Pages 295-298

  Ho, Son Fat ^a   Lao, Hio Fai ^a   Li, Kin ^a   Tse, Men Kin ^a  

^a Estrada Do Visconde de Sao Januario   (China)

Author keywords

Prostate cancer; Prostate specific antigen; Radical prostatectomy

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLEEDING; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; INTRAOPERATIVE PERIOD; LYMPHOCELE; MACAO; MAJOR CLINICAL STUDY; MALE; METASTASIS; NERVE INJURY; OBTURATOR NERVE; OPERATION DURATION; PATIENT SAFETY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RECTUM FISTULA; RECTUM INJURY; RECURRENCE RISK; TREATMENT RESPONSE; URETHRA STRICTURE; URINE INCONTINENCE; URINE RETENTION; FOLLOW UP; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSTATE TUMOR;

AGED; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 41649112775     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802020-00003     Document Type: Article

References (21)

1. Annual report of Macau Cancer Registry 2005. Department of Statistics Center of Health Government of Macau Special Administrative Region. Demography 2005.
2. Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinical localized prostate cancer in a population based cohort. J Urol 2007; 177: 932-936.
3. Tewari A, Raman JD, Chang P, Rao S, Divine G; Menon M. Long-term survival probability in men with clinically localized prostate cancer treated either conservatively or with definitive treatment (radiotherapy or radical prostatectomy). Urology 2006; 68: 1268-1274.
4. Hon M, Partin AW, Pound CP, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. Urol Clin North Am 2001; 28: 555-565.
5. Berglund RK, Jones JS, Ulchaker JC, Fergany A, Gill I, Kaouk J, et al. Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: A prospective analysis. Urology 2005; 67: 1253-1256.
6. Catalona WJ, Carvalhal GF, Mager DE, Smith DS. Potency, continence and complication rates in 1870 consecutive radical retropubic prostatectomies. J Urol 1999; 162: 433-438.
7. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical retropubic prostatectomy: Results at 10 years. J Urol 1994; 152: 1831-1839.
8. Shekarriz B., Upadhyay J, Wood DP. Intraoperative, perioperative, and long-term complications of radical prostatectomy. Urol Clin North Am 2001; 28: 639-652.
9. Borland RN, Walsh PC. The management of rectal injury during radical retropubic prostatectomy. J Urol 1992; 147: 905-912.
10. Lepor H, Nieder AM, Ferrandino MN. The intraeperative and postoperative complications following radical retropubic prostatectomy in a consecutive series of 1,000 cases. J Urol 2001; 166: 1729-1733.
11. Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker PD, Klein E, et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 2005; 66: 1245-1250.
12. Dahl DM, He W, Lazarus R, McDougal WS, Wu CL. Pathologic outcome of laparoscopic and open radical prostatectomy. Urology 2006; 68: 1253-1256.
13. Epstein JI. Pathologic assessment of the surgical specimen. Urol Clin North Am 2001; 28: 567-593.
14. Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm t, et al. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 2006; 24: 273-280.
15. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression following radical retropubic prostatectomy. Cancer 1993; 71: 3582-3588.
16. Watson RB, Civantos F, Soloway MS. Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. Urology 1996; 48: 80-92.
17. Shah O, Melamed J, Lepor H. Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol 2001; 165: 1943-1948.
18. Holmberg L, Bill-Axelson A, Garmo H, Palmgren J, Norlén BJ, Adami HO, et al. Prognostic markers under watchful waiting and radical prostatectomy. Hematol Oncol Clin N Am 2006; 20: 845-855.
19. Patel A, Dorey F, Franklin J, deKernion JB. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol 1997; 158: 1441-1445.
20. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevated following radical prostatectomy. JAMA 1999; 281: 1591-1957.
21. Amling CL. Biochemical recurrence after localized treatment. Urol Clin N Am 2006; 33: 147-159.